Allogene Therapeutics Inc (ALLO)

Operating Expenses

$184.96M

TTM · Period ending: · USD

ALLO logo

ALLO Operating Expenses

Latest reported$184.96M
ALLO Operating Expenses ($2.00K → $184.96M)
High-resolution chart · PNG

ALLO operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Allogene Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
194,574,000
273,221,000
327,832,000
321,397,000
294,281,000
246,702,000
202,008,000
192,842,000
2,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.